Intestinal methanogen overgrowth, unspecified
ICD-10 K63.829 is a billable code used to indicate a diagnosis of intestinal methanogen overgrowth, unspecified.
Intestinal methanogen overgrowth (IMO) is characterized by an excessive proliferation of methanogenic archaea in the gastrointestinal tract, particularly in the intestines. This condition can lead to symptoms such as bloating, abdominal pain, constipation, and altered bowel habits. The anatomy involved primarily includes the small and large intestines, where these microorganisms can disrupt normal digestion and fermentation processes. Disease progression may vary, with some patients experiencing chronic symptoms while others may have intermittent episodes. Diagnostic considerations for IMO often include breath tests that measure methane production, stool analysis, and clinical evaluation of gastrointestinal symptoms. It is essential to differentiate IMO from other gastrointestinal disorders, such as irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), as treatment approaches may differ significantly.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K63.829 covers intestinal methanogen overgrowth, which may present with symptoms like bloating, constipation, and abdominal discomfort. It is essential to confirm the diagnosis through appropriate testing, as it can overlap with other gastrointestinal conditions.
K63.829 should be used when there is a confirmed diagnosis of intestinal methanogen overgrowth, particularly when symptoms are present, and other conditions such as SIBO or IBS have been ruled out.
Documentation for K63.829 should include a detailed clinical history, symptomatology, results from breath tests or stool analysis, and any treatment plans. Clear differentiation from other gastrointestinal disorders is crucial.
